These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34813613)

  • 1. Correlates of survival after autoantibody reduction therapy for acute IPF exacerbations.
    Kulkarni T; Valentine VG; Fei F; Tran-Nguyen TK; Quesada-Arias LD; Mkorombindo T; Pham HP; Simmons SC; Dsouza KG; Luckhardt T; Duncan SR
    PLoS One; 2021; 16(11):e0260345. PubMed ID: 34813613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis.
    Donahoe M; Valentine VG; Chien N; Gibson KF; Raval JS; Saul M; Xue J; Zhang Y; Duncan SR
    PLoS One; 2015; 10(6):e0127771. PubMed ID: 26083430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis.
    Kulkarni T; Criner GJ; Kass DJ; Rosas IO; Scholand MB; Dilling DF; Summer R; Duncan SR
    BMC Pulm Med; 2024 Mar; 24(1):143. PubMed ID: 38509495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of the STRIVE-IPF Trial- Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis.
    Kulkarni T; Criner GJ; Kass DJ; Rosas IO; Scholand MB; Dilling DF; Summer R; Duncan SR
    Res Sq; 2024 Feb; ():. PubMed ID: 38464052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of autoantibody positivity in idiopathic pulmonary fibrosis.
    Ghang B; Lee J; Chan Kwon O; Ahn SM; Oh JS; Hong S; Kim YG; Yoo B; Jeong WS; Kim J; Lee CK
    Respir Med; 2019 Aug; 155():43-48. PubMed ID: 31299466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and economic burden of acute exacerbations of idiopathic pulmonary fibrosis: a prospective observational study in Spain (OASIS study).
    Gómez AV; Rodríguez-Nieto MJ; Cano-Jiménez E; Ortiz AR; Morros M; Ramon A; Armengol S
    BMC Pulm Med; 2024 Jul; 24(1):370. PubMed ID: 39080648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Hachisu Y; Murata K; Takei K; Tsuchiya T; Tsurumaki H; Koga Y; Horie T; Takise A; Hisada T
    Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31086028
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study.
    Tsushima K; Yamaguchi K; Kono Y; Yokoyama T; Kubo K; Matsumura T; Ichimura Y; Abe M; Terada J; Tatsumi K
    Pulm Pharmacol Ther; 2014 Dec; 29(2):233-40. PubMed ID: 24836398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
    Enomoto N; Naoi H; Aono Y; Katsumata M; Horiike Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    Ther Adv Respir Dis; 2020; 14():1753466620935774. PubMed ID: 32600180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyxin B-immobilized fiber column (PMX) treatment for idiopathic pulmonary fibrosis with acute exacerbation: a multicenter retrospective analysis.
    Abe S; Azuma A; Mukae H; Ogura T; Taniguchi H; Bando M; Sugiyama Y
    Intern Med; 2012; 51(12):1487-91. PubMed ID: 22728479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review.
    Luppi F; Cerri S; Taddei S; Ferrara G; Cottin V
    Intern Emerg Med; 2015 Jun; 10(4):401-11. PubMed ID: 25672832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
    Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
    Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses.
    Kahloon RA; Xue J; Bhargava A; Csizmadia E; Otterbein L; Kass DJ; Bon J; Soejima M; Levesque MC; Lindell KO; Gibson KF; Kaminski N; Banga G; Oddis CV; Pilewski JM; Sciurba FC; Donahoe M; Zhang Y; Duncan SR
    Am J Respir Crit Care Med; 2013 Apr; 187(7):768-75. PubMed ID: 23262513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of pirfenidone in idiopathic pulmonary fibrosis according to the autoantibody status: a retrospective cohort study.
    Song MJ; Lee SH; Jung JY; Kang YA; Park MS; Kim YS; Chang J; Kim SY
    BMC Pulm Med; 2021 May; 21(1):145. PubMed ID: 33941141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute exacerbations of COPD versus IPF in patients with combined pulmonary fibrosis and emphysema.
    Zantah M; Dotan Y; Dass C; Zhao H; Marchetti N; Criner GJ
    Respir Res; 2020 Jun; 21(1):164. PubMed ID: 32605574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): an overview of current and future therapeutic strategies.
    Biondini D; Balestro E; Sverzellati N; Cocconcelli E; Bernardinello N; Ryerson CJ; Spagnolo P
    Expert Rev Respir Med; 2020 Apr; 14(4):405-414. PubMed ID: 31994940
    [No Abstract]   [Full Text] [Related]  

  • 17. Survival in Idiopathic pulmonary fibrosis acute exacerbations: the non-steroid approach.
    Papiris SA; Kagouridis K; Kolilekas L; Papaioannou AI; Roussou A; Triantafillidou C; Baou K; Malagari K; Argentos S; Kotanidou A; Karakatsani A; Manali ED
    BMC Pulm Med; 2015 Dec; 15():162. PubMed ID: 26666385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Myxovirus Resistance Protein-1 Immunoglobulin A Autoantibody in Idiopathic Pulmonary Fibrosis.
    Arai T; Hirose M; Hamano Y; Kagawa T; Murakami A; Kida H; Kumanogoh A; Inoue Y
    Can Respir J; 2022; 2022():1107673. PubMed ID: 35391716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for Refractory Autoimmune Encephalitis.
    Yang J; Liu X
    Front Immunol; 2021; 12():790962. PubMed ID: 34975890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplantation Outcome.
    Dotan Y; Vaidy A; Shapiro WB; Zhao H; Dass C; Toyoda Y; Marchetti N; Shenoy K; Cordova FC; Criner GJ; Mamary AJ
    Chest; 2018 Oct; 154(4):818-826. PubMed ID: 29966665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.